Zhenghong Chang — Harbin Medical University

Area of research

Cancer Research · Molecular Biology

Research interest

Research focused on Computational biology and Regulon, with related work in RNA splicing, Epigenome, Enhancer. Notable publications include 'TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome', 'ImmReg: the regulon atlas of immune-related pathways across cancer types', and 'Pan-cancer characterization of expression and clinical relevance of m6A-related tissue-elevated long non-coding RNAs'.

Recent publications

TransLnc: a comprehensive resource for translatable lncRNAs extends immunopeptidome

Nucleic Acids Research 2021cited by 47position: middledoi

ImmReg: the regulon atlas of immune-related pathways across cancer types

Nucleic Acids Research 2021cited by 29position: middledoi

Pan-cancer characterization of expression and clinical relevance of m6A-related tissue-elevated long non-coding RNAs

Molecular Cancer 2021cited by 28position: middledoi

Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer

Molecular Therapy — Nucleic Acids 2021cited by 28position: middledoi

Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma

Theranostics 2021cited by 10position: middledoi

Revealing Epigenetic Factors of circRNA Expression by Machine Learning in Various Cellular Contexts

iScience 2020cited by 17position: middledoi

Integrated multifactor analysis explores core dysfunctional modules in autism spectrum disorder

International Journal of Biological Sciences 2018cited by 7position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cancer Research · Molecular Biology →